Turn.bio Company
![](/files/companies/Turn.jpeg)
Turn Biotechnologies develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. We are focused on reprogramming the epigenome – a network of chemical compounds and proteins that control cell functions by influencing which genes are active – to restore capabilities that are often lost with age.
Headquarters:
Mountain View, California, United States
Number Of Exists:
1-10
Founded Date:
Feb 2019
Employee Number:
1-10
Last Funding Type:
Funding Round
Investors Number:
5
Last Funding Date:
Apr 28, 2021
Funding Status:
Seed
Estimated Revenue:
Less than $1M
Industry:
Biotechnology, Gene therapy, Genetics, Health Care, Therapeutics